ETR Form 4: Director Karen Puckett receives 265 shares under stock program
Rhea-AI Filing Summary
Karen A. Puckett, a director of Entergy Corporation (ETR), reported an acquisition of common stock under the company's Director Stock Program. The transaction dated 09/02/2025 shows 265 shares acquired at a reported price of $0, and the reporting person beneficially owns 32,682 shares following the transaction. The Form 4 was signed by Daniel T. Falstad by power of attorney on 09/03/2025.
The filing reflects a routine director equity award rather than an open-market purchase or sale; no derivative transactions were reported and the shares are held directly. The form contains only the disclosure of this award and the updated beneficial ownership total.
Positive
- 265 shares acquired under Entergy's Director Stock Program, showing continued alignment of the director with shareholder interests
- Beneficial ownership updated to 32,682 shares, providing transparency on insider holdings
- No derivative transactions or sales reported in this filing, indicating no immediate disposition of shares
Negative
- None.
Insights
TL;DR: Routine director stock award of 265 shares; updates insider holdings to 32,682 shares.
This Form 4 documents a non‑market acquisition under Entergy's Director Stock Program. Such grants are standard compensation for board service and are typically non‑cash awards, consistent with the reported price of $0. The disclosure updates the director's beneficial ownership and contains no derivatives, sales, or unusual trading activity. For investors, this is routine governance reporting rather than a material corporate event.
TL;DR: Standard director equity grant reported; procedural signature by power of attorney noted.
The filing indicates a customary equity award to a director administered through the company stock program. The direct ownership amount post‑transaction is clearly stated. The signature by a named attorney under power of attorney is properly disclosed and dated. There are no red flags such as sales, option exercises, or unusual timing in this report; it aligns with routine board compensation disclosure practices.